Viewing nowGlicita Tablet 25mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 202102396 · Approved 2021.03.17 · Insurance code 657308550
Improvement of blood sugar control in type 2 diabetes
This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can be administered alone as an initial treatment, and if a patient has no prior treatment experience and struggles with blood sugar control, it can be used in combination with metformin. Additionally, this medication can be used in combination when blood sugar is not adequately controlled with any one of sulfonylureas, metformin, thiazolidinediones, or insulin. It can also be used in situations where multiple medications need to be combined but blood sugar control remains difficult. Therefore, this medication helps improve blood sugar management at various stages of treatment.
The usual dose of this medication is 100 mg once daily for either monotherapy or combination therapy, with a maximum daily dosage of 100 mg. It can be taken regardless of meals. For patients with renal impairment, dosage adjustment is necessary according to kidney function. - Mild renal impairment (eGFR ≥ 60 and < 90 mL/min/1.73 m2): No dosage adjustment required - Moderate renal impairment (eGFR ≥ 45 and < 60 mL/min/1.73 m2): Dosage adjustment is needed.
This medication can cause allergic reactions; if symptoms such as skin rash or difficulty breathing occur, discontinue use immediately and consult a physician. If severe abdominal pain, a symptom of pancreatitis, occurs while taking this medication, notify healthcare personnel immediately, and discontinue medication if necessary. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication. Patients with impaired renal function need dosage adjustment of this medication, so regular kidney function tests should be performed, and it should be taken according to physician’s instructions. There is a risk of hypoglycemia when taking this medication, especially when used in combination with insulin or sulfonylureas; blood sugar levels should be monitored frequently, and symptoms should be carefully observed. If severe joint pain or blisters on the skin occur, notify a physician immediately and discontinue medication. Pregnant or breastfeeding women are advised to avoid using this medication, and safety and effectiveness in children have not been established. Elderly patients may require dosage adjustments and regular kidney function tests due to potentially reduced renal function. In cases of overdose, seek medical attention immediately because this medication can be partially removed by dialysis. This medication has fewer drug interactions; however, when used in combination with digoxin, blood concentration levels should be monitored. If any abnormal symptoms occur while taking this medication, consult healthcare personnel immediately.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing (anaphylaxis), cold sweat, pallor, severe rash with fever, blisters, skin peeling, mucosal pain in the mouth/eyes (Stevens-Johnson syndrome), acute pancreatitis, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to ensure the prolonged effectiveness of the drug.
Pink, round double-convex film-coated tablets
28 tablets/box [14 tablets/PTPX2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.